Stock listing

Dusseldorf:19T Idorsia Ltd. Aktie

German listing (Dusseldorf) of Idorsia Ltd. · home listing SIX Swiss:IDIA

Follow Idorsia Ltd. into a list and get an email when it puts out news.

Home listing price · SIX:IDIA

4.10 CHF -0.10 (-2.3%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:IDIA

Since Jul 6, 2026 -37.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
4.03 – 4.22 CHFOct 16, 2026
Volume
811,026 sharesOct 16, 2026
Market value
1.10B CHFAt the close on Oct 16, 2026 · price × 269.1M shares outstanding
Idorsia Ltd. logo
Ticker
Dusseldorf:19T
Asset type
Stock
Exchange
Dusseldorf
Currency
EUR

What changed lately

Calls

Replays

  • Idorsia (SIX Swiss: IDIA) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 9:00 AM ET

    Watch Transcript

  • Idorsia (SIX Swiss: IDIA) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 8:00 AM ET

    Watch Transcript

  • Idorsia (SIX Swiss: IDIA) Q2 2025 Earnings Call

    Wed, Jul 30, 2025 · 8:00 AM ET

    Watch Transcript

Latest news

Idorsia acknowledges the DEA proposal to reclassify dual orexin receptor antagonists to the lowest schedule – Schedule V

Aug 11, 2026

QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth

Jul 30, 2026

Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant

Jul 27, 2026

Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call

Jul 23, 2026

Idorsia appoints Roland Wandeler as Chief Executive Officer

Jul 1, 2026

Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility

Jun 26, 2026

Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon

Jun 9, 2026

Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology

Jun 1, 2026

New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension

Jun 1, 2026

Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2026

May 6, 2026

All Idorsia Ltd. news

Decks

Idorsia Ltd. on 6ix

News releases
32 in the last 12 months · 72 in all · newest Aug 11, 2026 · oldest 2025
Calls
16 calls with a replay · 16 with a transcript · latest Jul 30, 2026
Decks
11 decks · latest Jul 30, 2026

Where Idorsia Ltd. is listed

ListingExchangeCountryCurrency
SIX Swiss:IDIA · Home listingSIX SwissSwitzerlandCHF
LSIN:0RQELSINUnited KingdomCHF
OTC:IDRSFOTCUnited StatesUSD
Lang & Schwarz:A2DTEBLang & SchwarzGermanyEUR
gettex:19TgettexGermanyEUR
LS Exchange:A2DTEBLS ExchangeGermanyEUR
BX Swiss:19TBX SwissSwitzerlandCHF
Tradegate:19TTradegateGermanyEUR
Aquis:IDIAZAquisUnited KingdomCHF
Frankfurt:19TFrankfurtGermanyEUR
Turquoise:IDIAZTurquoiseUnited KingdomCHF
Dusseldorf:19T · This pageDusseldorfGermanyEUR
Hamburg:19THamburgGermanyEUR
Munich:19TMunichGermanyEUR
Stuttgart:19TStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Idorsia Ltd.